About: Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?” Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”
Creator	Cure, Erkan Cure, Medine
Source	Elsevier; Medline; PMC
abstract	covid:7f2b59f3d181c7f76cb3f4aef0499df4c23f9c13#abstract
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.1016/j.diabres.2020.108184
bibo:pmid	32360695
has license	els-covid
sha1sum (hex)	7f2b59f3d181c7f76cb3f4aef0499df4c23f9c13
schema:url	https://doi.org/10.1016/j.diabres.2020.108184
resource representing a document's title	Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”
has PubMed Central identifier	PMC7190510
has PubMed identifier	32360695
schema:publication	Diabetes Res Clin Pract
resource representing a document's body	covid:7f2b59f3d181c7f76cb3f4aef0499df4c23f9c13#body_text
is schema:about of	named entity 'dapagliflozin' named entity 'Insulin' named entity 'Insulin' named entity 'diabetic ketoacidosis' named entity 'COVID-19 infection' named entity 'COVID-19 pandemic' named entity 'dapagliflozin' named entity 'dapagliflozin' named entity 'diabetic patients' named entity 'diabetes' named entity 'Diabetic ketoacidosis' named entity 'infection' named entity 'ACE2' named entity 'virus' named entity 'lactate' named entity 'Lactate' named entity 'Insulin' named entity 'Lactate dehydrogenase' named entity 'vicious circle' named entity 'COVID-19.' named entity 'intracellular pH' named entity 'lactate' named entity 'viral load' named entity 'angiotensin-converting enzyme 2' named entity 'blood sugar regulation' named entity 'lactate' named entity 'infection' named entity 'ion' named entity 'intracellular pH' named entity 'COVID-19' named entity 'cleavage' named entity 'insulin' named entity 'ADAM17' named entity 'insulin' named entity 'ACE2' named entity 'NHE' named entity 'Insulin' named entity 'ion' named entity 'ACE2' named entity 'insulin' named entity 'insulin' named entity 'Dapagliflozin' named entity 'dapagliflozin' named entity 'virus infection' named entity 'ACE2' named entity 'ADAM17' named entity 'NHE' named entity 'infection' named entity 'Metformin' named entity 'diabetes' named entity 'Dapagliflozin' named entity 'Lactate' named entity 'creatine kinase' named entity 'COVID-19 infection' named entity 'hypoxia' named entity 'anti-diabetic medications' named entity 'NHE' named entity 'lactate production' named entity 'ADAM17' named entity 'ACE2' named entity 'metformin' named entity 'coronavirus disease 2019' named entity 'lactate' named entity 'Dapagliflozin' named entity 'Insulin' named entity 'lactate production' named entity 'low pH' named entity 'intracellular' named entity 'ACE2' named entity 'dapagliflozin' named entity 'NHE' named entity 'LDH' named entity 'lactate' named entity 'cell signaling' named entity 'ACE2' named entity 'SGLT2 inhibitors' named entity 'Insulin therapy' named entity 'intracellular pH' named entity 'anaerobic glycolysis' named entity 'COVID-19 pandemic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software